The Ubiquitin-Proteasome System and Proteasome Inhibitors in Central Nervous System Diseases
Journal:
Cardiovascular & Hematological Disorders-Drug Targets
Volume:
7
Page:
250-273
Author(s):
Imtiaz M. Shah and Mario Di Napoli
Endocannabinoid Signaling in Midbrain Dopamine Neurons: More than Physiology?
Journal:
Current Neuropharmacology
Volume:
5
Page:
268-277
Author(s):
M. Melis and M. Pistis
The Neuropharmacology of (-)-Stepholidine and its Potential Applications
Journal:
Current Neuropharmacology
Volume:
5
Page:
289-294
Author(s):
Kechun Yang, Guozhang Jin and Jie Wu
RAGE: A Single Receptor for Several Ligands and Different Cellular Responses: The Case of Certain S100 Proteins
Journal:
Current Molecular Medicine
Volume:
7
Page:
711-724
Author(s):
Rosario Donato
RAGE: A Potential Target for Aβ-Mediated Cellular Perturbation in Alzheimers Disease
Journal:
Current Molecular Medicine
Volume:
7
Page:
735-742
Author(s):
Shi Du Yan, Xi Chen, Douglas G. Walker, Ann Marie Schmidt, Ottavio Arancio and Lih-Fen Lue
RAGE, Diabetes, and the Nervous System
Journal:
Current Molecular Medicine
Volume:
7
Page:
766-776
Author(s):
Cory Toth, Jose Martinez and Douglas W. Zochodne
ω -Phosphinyl-α -Amino Acids: Synthesis, and Development towards Use as Therapeutic Agents
Journal:
Current Organic Chemistry
Volume:
11
Page:
1635-1651
Author(s):
Nick J. Wardle, S. W. Annie Bligh and Harry R. Hudson
Editorial [ New Advances in Alzheimers Disease: From Biology to Therapy Guest Editor: Giuseppina Tesco ]
Journal:
Current Genomics
Volume:
8
Page:
484-485
Author(s):
Giuseppina Tesco
Current Therapeutic Options for Alzheimers Disease
Journal:
Current Genomics
Volume:
8
Page:
550-558
Author(s):
Alberto Lleo
Evidence for the Role of Luteinizing Hormone in Alzheimer Disease
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
7
Page:
300-303
Author(s):
Kate M. Webber, Gemma Casadesus, Richard L. Bowen, George Perry and Mark A. Smith